Ms Eil?sh Hardiman:

We had concerns, as the CMO said, around complication rates, which we raised. The executive initiated the internal review and sought the expertise of our colleagues in Boston to look at clinical quality care. We kept the board well briefed of this. It meets monthly. From a HSE perspective, there are two ways of reporting. One is a monthly performance meeting and the second is a patient safety protocol when there is a patient safety issue.